These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
555 related articles for article (PubMed ID: 26145478)
1. Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9. Chen Y; Cao J; Xiong M; Petersen AJ; Dong Y; Tao Y; Huang CT; Du Z; Zhang SC Cell Stem Cell; 2015 Aug; 17(2):233-44. PubMed ID: 26145478 [TBL] [Abstract][Full Text] [Related]
2. The iCRISPR platform for rapid genome editing in human pluripotent stem cells. Zhu Z; González F; Huangfu D Methods Enzymol; 2014; 546():215-50. PubMed ID: 25398343 [TBL] [Abstract][Full Text] [Related]
3. Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein. Kagita A; Lung MSY; Xu H; Kita Y; Sasakawa N; Iguchi T; Ono M; Wang XH; Gee P; Hotta A Stem Cell Reports; 2021 Apr; 16(4):985-996. PubMed ID: 33711268 [TBL] [Abstract][Full Text] [Related]
4. Conditional Gene Knockout in Human Cells with Inducible CRISPR/Cas9. Snijders KE; Cooper JD; Vallier L; Bertero A Methods Mol Biol; 2019; 1961():185-209. PubMed ID: 30912047 [TBL] [Abstract][Full Text] [Related]
5. An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells. González F; Zhu Z; Shi ZD; Lelli K; Verma N; Li QV; Huangfu D Cell Stem Cell; 2014 Aug; 15(2):215-226. PubMed ID: 24931489 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells. Santos DP; Kiskinis E; Eggan K; Merkle FT Curr Protoc Stem Cell Biol; 2016 Aug; 38():5B.6.1-5B.6.60. PubMed ID: 27532820 [TBL] [Abstract][Full Text] [Related]
7. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus. Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281 [TBL] [Abstract][Full Text] [Related]
8. Efficient CRISPR/Cas9-mediated biallelic gene disruption and site-specific knockin after rapid selection of highly active sgRNAs in pigs. Wang X; Zhou J; Cao C; Huang J; Hai T; Wang Y; Zheng Q; Zhang H; Qin G; Miao X; Wang H; Cao S; Zhou Q; Zhao J Sci Rep; 2015 Aug; 5():13348. PubMed ID: 26293209 [TBL] [Abstract][Full Text] [Related]
9. p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Ihry RJ; Worringer KA; Salick MR; Frias E; Ho D; Theriault K; Kommineni S; Chen J; Sondey M; Ye C; Randhawa R; Kulkarni T; Yang Z; McAllister G; Russ C; Reece-Hoyes J; Forrester W; Hoffman GR; Dolmetsch R; Kaykas A Nat Med; 2018 Jul; 24(7):939-946. PubMed ID: 29892062 [TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9-Mediated Insertion of loxP Sites in the Mouse Dock7 Gene Provides an Effective Alternative to Use of Targeted Embryonic Stem Cells. Bishop KA; Harrington A; Kouranova E; Weinstein EJ; Rosen CJ; Cui X; Liaw L G3 (Bethesda); 2016 Jul; 6(7):2051-61. PubMed ID: 27175020 [TBL] [Abstract][Full Text] [Related]
11. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Hou Z; Zhang Y; Propson NE; Howden SE; Chu LF; Sontheimer EJ; Thomson JA Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15644-9. PubMed ID: 23940360 [TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-Mediated Mutagenesis of Human Pluripotent Stem Cells in Defined Xeno-Free E8 Medium. Soh CL; Huangfu D Methods Mol Biol; 2017; 1498():57-78. PubMed ID: 27709569 [TBL] [Abstract][Full Text] [Related]
13. Pipeline for the Generation and Characterization of Transgenic Human Pluripotent Stem Cells Using the CRISPR/Cas9 Technology. Mianné J; Bourguignon C; Nguyen Van C; Fieldès M; Nasri A; Assou S; De Vos J Cells; 2020 May; 9(5):. PubMed ID: 32466123 [TBL] [Abstract][Full Text] [Related]
14. Genetic Modification in Human Pluripotent Stem Cells by Homologous Recombination and CRISPR/Cas9 System. Xue H; Wu J; Li S; Rao MS; Liu Y Methods Mol Biol; 2016; 1307():173-90. PubMed ID: 24615461 [TBL] [Abstract][Full Text] [Related]
15. Generation of Two Noradrenergic-Specific Dopamine-Beta-Hydroxylase-FLPo Knock-In Mice Using CRISPR/Cas9-Mediated Targeting in Embryonic Stem Cells. Sun JJ; Ray R PLoS One; 2016; 11(7):e0159474. PubMed ID: 27441631 [TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9-mediated targeting of the Rosa26 locus produces Cre reporter rat strains for monitoring Cre-loxP-mediated lineage tracing. Ma Y; Yu L; Pan S; Gao S; Chen W; Zhang X; Dong W; Li J; Zhou R; Huang L; Han Y; Bai L; Zhang L; Zhang L FEBS J; 2017 Oct; 284(19):3262-3277. PubMed ID: 28763160 [TBL] [Abstract][Full Text] [Related]
17. Generation of TGFBI knockout ABCG2+/ABCB5+ double-positive limbal epithelial stem cells by CRISPR/Cas9-mediated genome editing. Kim EK; Kim S; Maeng YS PLoS One; 2019; 14(2):e0211864. PubMed ID: 30753226 [TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9-based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells. Gupta N; Susa K; Yoda Y; Bonventre JV; Valerius MT; Morizane R Curr Protoc Stem Cell Biol; 2018 May; 45(1):e50. PubMed ID: 30040245 [TBL] [Abstract][Full Text] [Related]
19. Increasing Gene Editing Efficiency for CRISPR-Cas9 by Small RNAs in Pluripotent Stem Cells. Shahryari A; Moya N; Siehler J; Wang X; Burtscher I; Lickert H CRISPR J; 2021 Aug; 4(4):491-501. PubMed ID: 34406042 [TBL] [Abstract][Full Text] [Related]
20. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Paquet D; Kwart D; Chen A; Sproul A; Jacob S; Teo S; Olsen KM; Gregg A; Noggle S; Tessier-Lavigne M Nature; 2016 May; 533(7601):125-9. PubMed ID: 27120160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]